96611-83-5

Basic information

• Product Name: 3β-hydroxy-20-oxo-5α-pregnan-21-yl acetate
• Synonyms: 3β-hydroxy-20-oxo-5α-pregnan-21-yl acetate
• CAS NO: 96611-83-5
• Molecular Weight: 376.536
• Mol File: 96611-83-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3β-hydroxy-20-oxo-5α-pregnan-21-yl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: 3β-hydroxy-20-oxo-5α-pregnan-21-yl acetate(96611-83-5)
• EPA Substance Registry System: 3β-hydroxy-20-oxo-5α-pregnan-21-yl acetate(96611-83-5)

Safety Data

• Hazardous Substances Data: 96611-83-5(Hazardous Substances Data)

Upstream product

• 516-55-2 isopregnanolone 
• 546-67-8 lead(IV) tetraacetate 
• 566-78-9 21-acetoxypregnenolone 
• 64-19-7 acetic acid 

Downstream Products

• 567-02-2 (3β,5α)-3,21-dihydroxypregnan-20-one 
• 567-02-2 tetrahydroxydeoxycorticosterone 
• 4131-27-5 21-acetoxy-3β-(toluene-4-sulfonyloxy)-5α-pregnan-20-one 
• 40129-02-0 3β,21-diacetoxy-5α-pregnan-20-one 

Relevant articles and documents

INHIBITORS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE FOR TREATING CARDIOVASCULAR AND PULMONARY CONDITIONS

The present disclosure provides for methods of treating or preventing a cardiovascular disorder and/or a related pulmonary disorder in a subject. In certain embodiments, the method comprises administering a therapeutically effective amount of an inhibitor of Glucose-6-phosphate dehydrogenase (G6PD), or a pharmaceutically acceptable salt, non-salt amorphous form, solvate, poly-morph, tautomer or prodrug thereof.

METHODS, COMPOSITIONS, AND COMPOUNDS FOR ALLOSTERIC MODULATION OF THE GABA RECEPTOR BY MEMBERS OF THE ANDROSTANE AND PREGNANE SERIES

Method, compositions, and compounds for modulating brain excitability to alleviate stress, anxiety, insomnia and seizure activity using certain steroid derivatives that act at a newly identified site on the gamma-aminobutyric acid receptor-chloride ionophore (GR) complex.